142 related articles for article (PubMed ID: 9580859)
1. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease.
Shreve PD
Eur J Nucl Med; 1998 Mar; 25(3):259-64. PubMed ID: 9580859
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer.
Imdahl A; Nitzsche E; Krautmann F; Högerle S; Boos S; Einert A; Sontheimer J; Farthmann EH
Br J Surg; 1999 Feb; 86(2):194-9. PubMed ID: 10100786
[TBL] [Abstract][Full Text] [Related]
3. [The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
Voth M; Opfermann T; Gottschild D
Zentralbl Chir; 2003 May; 128(5):375-8. PubMed ID: 12813634
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?
Nitzsche EU; Hoegerle S; Mix M; Brink I; Otte A; Moser E; Imdahl A
Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):237-42. PubMed ID: 11926386
[TBL] [Abstract][Full Text] [Related]
5. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
6. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Friess H; Langhans J; Ebert M; Beger HG; Stollfuss J; Reske SN; Büchler MW
Gut; 1995 May; 36(5):771-7. PubMed ID: 7797130
[TBL] [Abstract][Full Text] [Related]
8. [Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].
Zimny M; Schumpelick V
Chirurg; 2001 Sep; 72(9):989-94. PubMed ID: 11594284
[TBL] [Abstract][Full Text] [Related]
9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography.
Ozaki Y; Oguchi K; Hamano H; Arakura N; Muraki T; Kiyosawa K; Momose M; Kadoya M; Miyata K; Aizawa T; Kawa S
J Gastroenterol; 2008; 43(2):144-51. PubMed ID: 18306988
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.
van Kouwen MC; Jansen JB; van Goor H; de Castro S; Oyen WJ; Drenth JP
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):399-404. PubMed ID: 15549297
[TBL] [Abstract][Full Text] [Related]
12. Imaging findings of immune checkpoint inhibitor associated pancreatitis.
Das JP; Postow MA; Friedman CF; Do RK; Halpenny DF
Eur J Radiol; 2020 Oct; 131():109250. PubMed ID: 32905952
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET evaluation of indeterminate pancreatic masses.
Ho CL; Dehdashti F; Griffeth LK; Buse PE; Balfe DM; Siegel BA
J Comput Assist Tomogr; 1996; 20(3):363-9. PubMed ID: 8626891
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Cancer Complicated by Pancreatitis Demonstrated on FDG PET/CT.
Hennessy G; Vamadevan S; Loh H; Bui C; Le K; Mansberg R
Clin Nucl Med; 2017 Mar; 42(3):239-240. PubMed ID: 28098664
[TBL] [Abstract][Full Text] [Related]
15. Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations.
Sendler A; Avril N; Helmberger H; Stollfuss J; Weber W; Bengel F; Schwaiger M; Roder JD; Siewert JR
World J Surg; 2000 Sep; 24(9):1121-9. PubMed ID: 11036292
[TBL] [Abstract][Full Text] [Related]
16. Hypermetabolic lesions of the pancreas on FDG PET/CT.
Dong A; Dong H; Zhang L; Zuo C
Clin Nucl Med; 2013 Sep; 38(9):e354-66. PubMed ID: 23486316
[TBL] [Abstract][Full Text] [Related]
17. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.
Bares R; Klever P; Hauptmann S; Hellwig D; Fass J; Cremerius U; Schumpelick V; Mittermayer C; Büll U
Radiology; 1994 Jul; 192(1):79-86. PubMed ID: 8208970
[TBL] [Abstract][Full Text] [Related]
18. [Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma].
Bares R; Dohmen BM; Cremerius U; Fass J; Teusch M; Büll U
Radiologe; 1996 May; 36(5):435-40. PubMed ID: 8778929
[TBL] [Abstract][Full Text] [Related]
19. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
20. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
